A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
Exp Hematol Oncol
; 7: 18, 2018.
Article
em En
| MEDLINE
| ID: mdl-30123673
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
Idioma:
En
Revista:
Exp Hematol Oncol
Ano de publicação:
2018
Tipo de documento:
Article